Anthocyanin-rich purple corn extract inhibit diabetes-associated glomerular angiogenesis

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Kang, Min Kyung ^a   Lim, Soon Sung ^a   Lee, Jae Yong ^a   Yeo, Kyung Mok ^b   Kang, Young Hee ^a  

^a Hallym University   (South Korea)

^b S and D Co Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANTHOCYANIN; ANTIDIABETIC AGENT; BETA3 INTEGRIN; BIOLOGICAL MARKER; CD31 ANTIGEN; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 67 ANTIGEN; PLANT EXTRACT; PURPLE CORN EXTRACT; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; KIDNEY FAILURE; MALE; MESANGIUM CELL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; TREATMENT OUTCOME;

ANIMALS; ANTHOCYANINS; ANTIGENS, CD; ANTIGENS, CD31; BLOTTING, WESTERN; CADHERINS; CELL LINE; CELL PROLIFERATION; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTEGRIN BETA3; KIDNEY GLOMERULUS; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; PLANT EXTRACTS; THROMBOSPONDIN 1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZEA MAYS;

EID: 84894236068     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079823     Document Type: Article

References (41)

1. Nguyen DV, Shaw LC, Grant MB (2012) Inflammation in the pathogenesis of microvascular complications in diabetes. Front Endocrinol (Lausanne) 3: 170.
2. Willard AL, Herman IM (2012) Vascular complications and diabetes: current therapies and future challenges. J Ophthalmol 2012: 209538.
3. Nakagawa T, Kosugi T, Haneda M, Rivard CJ, Long DA (2009) Abnormal angiogenesis in diabetic nephropathy. Diabetes 58: 1471-1478.
4. Miyata T, de Strihou CV (2010) Diabetic nephropathy: a disorder of oxygen metabolism? Nat Rev Nephrol 6: 83-95.
5. Sivaskandarajah GA, Jeansson M, Maezawa Y, Eremina V, Baelde HJ, et al. (2012) VEGF-A protects the glomerular microvasculature in diabetes. Diabetes 61: 2958-2966.
6. Sun YM, Su Y, Li J, Wang LF (2013) Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochem Biophys Res Commun 433: 359-361.
7. Advani A, Gilbert RE (2012) The endothelium in diabetic nephropathy. Semin Nephrol 32: 199-207.
8. Costa PZ, Soares R (2013) Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox. Life Sci 92: 1037-1045.
9. Gu HF, Zheng X, Abu Seman N, Gu T, Botusan IR, et al. (2013) Impact of the hypoxia-inducible factor-1α (HIF1A) Pro582Ser polymorphism on diabetes nephropathy. Diabetes Care 36: 415-421.
10. Crawford TN, Alfaro DV 3rd, Kerrison JB, Jablon EP (2009) Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 5: 8-13.
11. Ballermann BJ (2007) Contribution of the endothelium to the glomerular permselectivity barrier in health and disease. Nephron Physiol 106: 19-25.
12. Fernandez PM, Patierno SR, Rickles FR (2004) Tissue factor and fibrin in tumor angiogenesis. Semin Thromb Hemost 30: 31-44. (Pubitemid 38457299)
13. Zent R, Pozzi A (2007) Angiogenesis in diabetic nephropathy. Semin Nephrol 27: 161-171. (Pubitemid 46566340)
14. Saito D, Maeshima Y, Nasu T, Yamasaki H, Tanabe K, et al. (2011) Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis. Am J Physiol Renal Physiol 300: F873-F886.
15. Maeshima Y (2005) Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells. Clin Exp Nephrol 9: 271-281.
16. Satchell SC, Mathieson PW (2003) Angiopoietins: microvascular modulators with potential roles in glomerular pathophysiology. J Nephrol 16: 168-178. (Pubitemid 37304072)
17. Khoury CC, Ziyadeh FN (2011) Angiogenic factors. Contrib Nephrol 170: 83-92.
18. Kim TH, Kim JK, Kang YH, Lee JY, Kang IJ, et al. (2013) Aldose Reductase Inhibitory Activity of Compounds from Zea mays L. Biomed Res Int 2013: 727143.
19. Long N, Suzuki S, Sato S, Naiki-Ito A, Sakatani K, et al. (2013) Purple corn color inhibition of prostate carcinogenesis by targeting cell growth pathways. Cancer Sci 104: 298-303.
20. Kang MK, Li J, Kim JL, Gong JH, Kwak SN, et al. (2012) Purple corn anthocyanins inhibit diabetes-associated glomerular monocyte activation and macrophage infiltration. Am J Physiol Renal Physiol 303: F1060-F1069.
21. Li J, Kang MK, Kim JK, Kim JL, Kang SW, et al. (2012) Purple corn anthocyanins retard diabetes-associated glomerulosclerosis in mesangial cells and db/db mice. Eur J Nutr 51: 961-973.
22. Tanaka J, Nakamura S, Tsuruma K, Shimazawa M, Shimoda H, et al. (2012) Purple rice (Oryza sativa L.) extract and its constituents inhibit VEGF-induced angiogenesis. Phytother Res 26: 214-222.
23. Li J, Lim SS, Lee JY, Kim JK, Kang SW, et al. (2012) Purple corn anthocyanins dampened high-glucose-induced mesangial fibrosis and inflammation: possible renoprotective role in diabetic nephropathy. J Nutr Biochem 23: 320-331.
24. Kolavennu V, Zeng L, Peng H, Wang Y, Danesh FR (2008) Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes 57: 714-723.
25. Choi S, Park MS, Lee YR, Lee YC, Kim TW, et al. (2013) A standardized bamboo leaf extract inhibits monocyte adhesion to endothelial cells by modulating vascular cell adhesion protein-1. Nutr Res Pract 7: 9-14.
26. Sid B, Sartelet H, Bellon G, El Btaouri H, Rath G, et al. (2004) Thrombospondin 1: a multifunctional protein implicated in the regulation of tumor growth. Crit Rev Oncol Hematol 49: 245-258. (Pubitemid 38251356)
27. Smadja DM, d'Audigier C, Bièche I, Evrard S, Mauge L, et al. (2011) Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties. Arterioscler Thromb Vasc Biol 31: 551-559.
28. Lee HS, Han J, Bai HJ, Kim KW (2009) Brain angiogenesis in developmental and pathological processes: regulation, molecular and cellular communication at the neurovascular interface. FEBS J 276: 4622-35.
29. Bruns AF, Herbert SP, Odell AF, Jopling HM, Hooper NM, et al. (2010) Ligand-stimulated VEGFR2 signaling is regulated by co-ordinated trafficking and proteolysis. Traffic 11: 161-174.
30. Tait CR, Jones PF (2004) Angiopoietins in tumours: the angiogenic switch. J Pathol 204: 1-10. (Pubitemid 39214476)
31. Hohenstein B, Hausknecht B, Boehmer K, Riess R, Brekken RA, et al. (2006) Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int 69: 1654-1661.
32. Savage CO (1994) The biology of the glomerulus: endothelial cells. Kidney Int 45: 314-319.
33. Lokmic Z, Musyoka J, Hewitson TD, Darby IA (2012) Hypoxia and hypoxia signaling in tissue repair and fibrosis. Int Rev Cell Mol Biol 296: 139-185.
34. Westra J, Molema G, Kallenberg CG (2010) Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis - therapeutic implications. Curr Med Chem 17: 254-263.
35. Favot L, Martin S, Keravis T, Andriantsitohaina R, Lugnier C (2003) Involvement of cyclin-dependent pathway in the inhibitory effect of delphinidin on angiogenesis. Cardiovasc Res 59: 479-487. (Pubitemid 37272042)
36. Matsunaga N, Tsuruma K, Shimazawa M, Yokota S, Hara H (2010) Inhibitory actions of bilberry anthocyanidins on angiogenesis. Phytother Res 24: S42-S47.
37. Dessapt-Baradez C, Woolf AS, White KE, Pan J, Huang JL, et al. (2013) Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease. J Am Soc Nephrol, Epub ahead of print.
38. Woolf AS, Gnudi L, Long DA (2009) Roles of angiopoietins in kidney development and disease. J Am Soc Nephrol 20: 239-244.
39. Siddiqui IA, Malik A, Adhami VM, Asim M, Hafeez BB, et al. (2008) Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 27: 2055-2063. (Pubitemid 351442738)
40. Tanaka T, Nangaku M (2013) Angiogenesis and hypoxia in the kidney. Nat Rev Nephrol 9: 211-222.
41. Ichinose K, Maeshima Y, Yamamoto Y, Kinomura M, Hirokoshi K, et al. (2006) 2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice. Diabetes 55: 1232-1242. (Pubitemid 44195359)